Aandelen in “Tandheelkundige laboratoria”

Aandeel Datum Koers Evolutie
vlag PHSC 26/04 22,000 GBX
0,00% 		0,00%
vlag Premier Diversified Holdings Inc 14/08 0,055 CAD
-8,33% 		-8,33%
vlag Premier Inc 29/04 21,160 USD
+0,95% 		+0,95%
vlag Psychemedics Corp. 29/04 2,570 USD
+0,78% 		+0,78%

Nieuws over “Tandheelkundige laboratoria”

29/04 · Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B · Persbericht

29/04 · Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B · Persbericht

25/04 · Labcorp Announces 2024 First Quarter Results · Persbericht

25/04 · Labcorp Announces Winning Bid for Select Assets of Invitae · Persbericht

25/04 · Invitae Enters into Agreement with Labcorp for Sale of Business · Persbericht

24/04 · Bedrijfsnieuws uit Amerika · Bolero.be

Pepsico boekte 1% hogere omzet bij lagere volumes Het drankenbedrijf boekte een omzetgroei van 1% bij een daling van de volumes. Pepsico verdiende 1,61 dollar per aandeel , hoger dan de gemiddelde analistenverwachtingen...

23/04 · Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024 · Persbericht

22/04 · Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's Disease · Persbericht

19/04 · Concord Medical Files 2023 Annual Report on Form 20-F · Persbericht

15/04 · Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw · Persbericht

12/04 · PHSC Plc - Update re: Director's Shareholding · Persbericht

11/04 · Labcorp Declares Quarterly Dividend · Persbericht

10/04 · Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit · Persbericht

8/04 · Zillow Group to Announce First-Quarter 2024 Results May 1 · Persbericht

8/04 · Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs · Persbericht

5/04 · Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical Research · Persbericht

3/04 · PHSC Plc - Holding(s) in Company · Persbericht

2/04 · Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay · Persbericht

2/04 · Labcorp to Present Diverse Portfolio of Precision Oncology Research at the Annual Meeting of the American Association for Cancer Research · Persbericht

2/04 · PHSC Plc - Replacement RNS: Transaction in Own Shares and Completion of Buyback Programme · Persbericht

2/04 · PHSC Plc - Transaction in Own Shares and Completion of Buyback Programme · Persbericht

Mijn selecties